Hsiao-Wen Kao

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Chin-Hsuan Chuang, Ming-Chung Kuo, Hung Chang, Jin-Hou Wu, Yu-Shin Hung, Che-Wei Ou, Tung-Liang Lin, Yi-Jiun Su, Yuen-Chin Ong, Lee-Yung Shih, Hsiao-Wen Kao
Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan. Clinical and experimental medicine (2023)
Hsiao-Wen Kao, Ming-Chung Kuo, Ying-Jung Huang, Hung Chang, Shu-Fen Hu, Chein-Fuang Huang, Yu-Shin Hung, Tung-Liang Lin, Che-Wei Ou, Ming-Yu Lien, Jin-Hou Wu, Chih-Cheng Chen, Lee-Yung Shih
Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML. Cancers 14 (24) (2022)
Hsiao-Wen Kao, Ming-Chung Kuo, Ying-Jung Huang, Hung Chang, Shu-Fen Hu, Chein-Fuang Huang, Yu-Shin Hung, Tung-Liang Lin, Che-Wei Ou, Ming-Yu Lien, Jin-Hou Wu, Chih-Cheng Chen, Lee-Yung Shih
Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML. Cancers 14 (24) (2022)
Hsiao-Wen Kao, Ming-Chung Kuo, Ying-Jung Huang, Hung Chang, Shu-Fen Hu, Chein-Fuang Huang, Yu-Shin Hung, Tung-Liang Lin, Che-Wei Ou, Ming-Yu Lien, Jin-Hou Wu, Chih-Cheng Chen, Lee-Yung Shih
Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML. Cancers 14 (24) (2022)

Hsiao-Wen Kao.css-eqlu8i{font-size:small;padding-left:4px;}